Skip to main content
. 2023 Dec 12;13:22000. doi: 10.1038/s41598-023-49199-7

Figure 3.

Figure 3

SIRT6 prevents tumor cells from Delta16HER2-induced G2/M arrest and senescence. (A) Ex vivo cell cycle analysis of cell suspensions derived from Delta16HER2 and Delta16HER2/SIRT6-OE tumors at 20 weeks of age (top panels) and at 30 weeks of age (bottom panels). DNA content was evaluated by flow cytometry using propidium iodide (PI) staining (n = 3) and then analyzed using Dean-Jett-Fox algorithm in FlowJo software. Percentages of cells in each cell cycle phase are summarized in each panel. (B) Immunoblot image and quantification of Cyclin D1 and Cyclin E levels normalized to β-Actin in tumors of either 20- (top) or 30-week-old (bottom) Delta16HER2 and Delta16HER2/SIRT6-OE mice (n = 4). (C) mRNA expression of Trp53, Cdkn2a and Cdkn1a genes normalized to β-Actin mRNA level in tumors of 30-week-old Delta16HER2 controls and Delta16HER2/SIRT6-OE mice (n = 4/group). (D) Detection of senescence-associated β-galactosidase (SA-β-Gal) activity in frozen tumors of 30-week-old Delta16HER2 and Delta16HER2/SIRT6-OE (n = 3). Quantification is expressed as % of SA-β-Gal positive area (blue) with respect to the total section area. Scale bar, 25 mm. In (BD) ns p > 0.05, *p < 0.05, **p < 0.01, ***p < 0.001 (two-tailed unpaired t test). Error bars represent SD. See also Fig. S2.